Showing results (91-100 of 172) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphomaYasuhiro Oki, Daniela Buglio, Michelle Fanale, et al.Blood|October 5, 2017
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphomaBarbara Pro, Ranjana Advani, Pauline Brice, et al.British Journal of Haematology|January 20, 2007
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphomaNam H Dang, Barbara Pro, Fredrick B Hagemeister, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer CenterQi Liu, Luis Fayad, Fernando Cabanillas, et al.British Journal of Haematology|June 10, 2010
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphomaJorge E Romaguera, Luis E Fayad, Lei Feng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphomaJohn F Seymour, Barbara Pro, Lillian M Fuller, et al.British Journal of Haematology|July 22, 2014
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJason R Westin, Peter McLaughlin, Jorge Romaguera, et al.British Journal of Haematology|July 22, 2014
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky diseaseFelipe Samaniego, Zuzana Berkova, Jorge E Romaguera, et al.Cancer|August 28, 2003
Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapyBouthaina S Dabaja, Peter McLaughlin, Chul S Ha, et al.Seminars in Oncology|December 18, 2017
Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironmentLekha Mikkilineni, Diana Whitaker-Menezes, Marina Domingo-Vidal, et al.Pageof 18